Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.42
-0.19 (-1.40%)
Mar 2, 2026, 4:00 PM EST - Market closed
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $816.36 million as of March 3, 2026. Its market cap has decreased by -61.91% in one year.
Market Cap
816.36M
Enterprise Value
-128.07M
1-Year Change
-61.91%
Ranking
Category
Stock Price
$13.42
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $816.36M, an increase of 33.02%. That is a compound annual growth rate of 6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 816.36M | -1.65% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 856.44M |
| Omeros | 849.39M |
| Prime Medicine | 825.00M |
| Annexon | 822.79M |
| KalVista Pharmaceuticals | 811.77M |
| Evommune | 807.33M |
| BridgeBio Oncology Therapeutics | 806.29M |
| Eikon Therapeutics | 803.29M |